BACKGROUND: The traditional consensus diagnosis (ConsDx) of normal cognition, mild cognitive impairment (MCI), and dementia relies on the reconciliation of an informant-based report of cognitive and functional impairment by a physician diagnosis (PhyDx), and a neuropsychological diagnosis (NPDx). As this procedure may be labor intensive and influenced by the philosophy and biases of a clinician, the diagnostic algorithm (AlgDx) was developed to identify individuals as cognitively normal, with MCI, or dementia. METHODS: The AlgDx combines the PhyDx with the NPDx, using a diagnostic algorithm that provides cognitive diagnoses, as defined by the National Alzheimer Coordinating Center/Uniform Data Set nomenclature. Reliability of the AlgDx was assessed in 532 community-dwelling elderly subjects by its concordance with the ConsDx and association with two biomarkers, medial temporal atrophy (MTA) scores of brain magnetic resonance imaging scans, and Apolipoprotein E (ApoE)-epsilon4 genotype. RESULTS: A high degree of concordance was observed between ConsDx and AlgDx with a weighted Cohen's kappa of 0.84. Concordance of the AlgDx to the same ConsDx categories ranged from 85% to 92%. Excellent discriminative validity was observed using AlgDx, MTA scores, and ApoE-epsilon4 allele frequencies, each of which distinguished subjects with amnestic MCI and dementia from normal subjects. CONCLUSION: The AlgDx of normal cognition, MCI, and dementia is a valid alternative that reduces time, effort, and biases associated with the ConsDx. The inherent reliability of a fixed algorithm, together with its efficiency and avoidance of individual bias, suggests the AlgDx may be used in longitudinal, multisite clinical trials, and population studies of MCI and dementia.
BACKGROUND: The traditional consensus diagnosis (ConsDx) of normal cognition, mild cognitive impairment (MCI), and dementia relies on the reconciliation of an informant-based report of cognitive and functional impairment by a physician diagnosis (PhyDx), and a neuropsychological diagnosis (NPDx). As this procedure may be labor intensive and influenced by the philosophy and biases of a clinician, the diagnostic algorithm (AlgDx) was developed to identify individuals as cognitively normal, with MCI, or dementia. METHODS: The AlgDx combines the PhyDx with the NPDx, using a diagnostic algorithm that provides cognitive diagnoses, as defined by the National Alzheimer Coordinating Center/Uniform Data Set nomenclature. Reliability of the AlgDx was assessed in 532 community-dwelling elderly subjects by its concordance with the ConsDx and association with two biomarkers, medial temporal atrophy (MTA) scores of brain magnetic resonance imaging scans, and Apolipoprotein E (ApoE)-epsilon4 genotype. RESULTS: A high degree of concordance was observed between ConsDx and AlgDx with a weighted Cohen's kappa of 0.84. Concordance of the AlgDx to the same ConsDx categories ranged from 85% to 92%. Excellent discriminative validity was observed using AlgDx, MTA scores, and ApoE-epsilon4 allele frequencies, each of which distinguished subjects with amnestic MCI and dementia from normal subjects. CONCLUSION: The AlgDx of normal cognition, MCI, and dementia is a valid alternative that reduces time, effort, and biases associated with the ConsDx. The inherent reliability of a fixed algorithm, together with its efficiency and avoidance of individual bias, suggests the AlgDx may be used in longitudinal, multisite clinical trials, and population studies of MCI and dementia.
Authors: Shiming Ye; Yadong Huang; Karin Müllendorff; Liming Dong; Gretchen Giedt; Elaine C Meng; Fred E Cohen; Irwin D Kuntz; Karl H Weisgraber; Robert W Mahley Journal: Proc Natl Acad Sci U S A Date: 2005-12-12 Impact factor: 11.205
Authors: Kimberly A Schafer; Rochelle E Tractenberg; Mary Sano; Joan A Mackell; Ronald G Thomas; Anthony Gamst; Leon J Thal; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2004 Oct-Dec Impact factor: 2.703
Authors: David A Loewenstein; Amarilis Acevedo; Raymond Ownby; Joscelyn Agron; Warren W Barker; Richard Isaacson; Silvia Strauman; Ranjan Duara Journal: Am J Geriatr Psychiatry Date: 2006-11 Impact factor: 4.105
Authors: William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein Journal: Arch Neurol Date: 2006-01
Authors: Duane L Beekly; Erin M Ramos; William W Lee; Woodrow D Deitrich; Mary E Jacka; Joylee Wu; Janene L Hubbard; Thomas D Koepsell; John C Morris; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2007 Jul-Sep Impact factor: 2.703
Authors: R Duara; D A Loewenstein; E Potter; J Appel; M T Greig; R Urs; Q Shen; A Raj; B Small; W Barker; E Schofield; Y Wu; H Potter Journal: Neurology Date: 2008-12-09 Impact factor: 9.910
Authors: Ranjan Duara; David A Loewenstein; Maria T Greig; Elizabeth Potter; Warren Barker; Ashok Raj; John Schinka; Amy Borenstein; Michael Schoenberg; Yougui Wu; Jessica Banko; Huntington Potter Journal: Am J Geriatr Psychiatry Date: 2011-11 Impact factor: 4.105
Authors: Jeannie-Marie S Leoutsakos; Sarah N Forrester; Constantine G Lyketsos; Gwenn S Smith Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Saman Sargolzaei; Arman Sargolzaei; Mercedes Cabrerizo; Gang Chen; Mohammed Goryawala; Alberto Pinzon-Ardila; Sergio M Gonzalez-Arias; Malek Adjouadi Journal: Neuroinformatics Date: 2015-10
Authors: David R Weir; Robert B Wallace; Kenneth M Langa; Brenda L Plassman; Robert S Wilson; David A Bennett; Ranjan Duara; David Loewenstein; Mary Ganguli; Mary Sano Journal: Alzheimers Dement Date: 2011-01 Impact factor: 21.566
Authors: Ranjan Duara; David A Loewenstein; Qian Shen; Warren Barker; Elizabeth Potter; Daniel Varon; Kristen Heurlin; Rik Vandenberghe; Christopher Buckley Journal: Alzheimers Dement Date: 2012-11-22 Impact factor: 21.566